Carrière I et al: Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population. Arch Intern Med 2009;169:1317.
Casaburi R et al: Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005;127:809.
Chapple CR et al: A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: Results of the STAR trial. Eur Urol 2005;48:464.
Cohen JS et al: Dual therapy strategies for COPD: The scientific rationale for LAMA+LABA. Int J Chron Obstruct Pulmon Dis 2016;11:785.
Ehlert FJ, Pak KJ, Griffin MT: Muscarinic agonists and antagonists: Effects on gastrointestinal function. In: Fryer AD et al (editors): Muscarinic Receptors. Handb Exp Pharmacol 2012;208:343.
Filson CP et al: The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: A meta-analysis. J Urol 2013;190:2013.
Fowler CJ, Griffiths D, de Groat WC: The neural control of micturition. Nat Rev Neurosci 2008;9:453.
Kranke P et al: The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesth Analg 2002;95:133.
Kruse AC et al: Muscarinic acetylcholine receptors: Novel opportunities for drug development. Nat Rev Drug Discov 2014;13:549.
Lawrence GW, Aoki KR, Dolly JO: Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin A consistent with co-release of transmitters from efferent fibers. J Pharmacol Exp Ther 2010;334:1080.
Marquardt K: Mushrooms, amatoxin type. In: Olson K (editor): Poisoning & Drug Overdose, 6th ed. New York: McGraw-Hill, 2012.
Profita M et al: Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease. J Pharmacol Exp Ther 2009;329:753.
Rai BP et al: Anticholinergic drugs versus non-drug active therapies for nonneurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev 2012;12:CD003193.
Tauterman CS et al: Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor. J Med Chem 2013;56:8746.
Thai DM et al: Crystal structures of the M1 and M4 muscarinic acetylcholine receptors. Nature 2016;335:2016.
Wallukat G, Schimke I: Agonistic autoantibodies directed against G-proteincoupled receptors and their relationship to cardiovascular diseases. Semin Immunopathol 2014;36:351.
Young JM et al: Mecamylamine: New therapeutic uses and toxicity/risk profile. Clin Ther 2001;23:532.